The network of glycans on gp120 is of particular interest with regards to HIV-1 vaccine design, because the glycans both serve as targets for many classes of broadly neutralizing antibodies[29–32], and contribute to patterns of immune evasion and escape during HIV-1 infection[33–39]. This evidence concerns the gene ITIH4 and HIV-1 infection.